ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE

ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE was reported 160919 times

ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRESBYACUSIS 140 0.4545
1 BLOOD PRESSURE DIASTOLIC ABNORMAL 1100 0.4321
2 BLOOD PRESSURE SYSTOLIC ABNORMAL 974 0.3937
3 NEUROLOGIC NEGLECT SYNDROME 173 0.3112
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 173 0.3084
5 C-REACTIVE PROTEIN 212 0.2287
6 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1437 0.2210
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 442 0.2207
8 PLEURAL THICKENING 149 0.2178
9 X-RAY ABNORMAL 387 0.2162
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 438 0.2112
11 MUSCLE INJURY 1748 0.2108
12 LUPUS VULGARIS 263 0.2087
13 CAROTID ARTERY THROMBOSIS 177 0.2085
14 AUTISM SPECTRUM DISORDER 1127 0.2045
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 128 0.1916
16 TEMPERATURE REGULATION DISORDER 415 0.1861
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1326 0.1849
18 PLEURAL FIBROSIS 184 0.1806
19 DUODENAL ULCER PERFORATION 1295 0.1740
20 DISLOCATION OF VERTEBRA 396 0.1735
21 FOLLICULITIS 1813 0.1727
22 SWOLLEN JOINT COUNT INCREASED 526 0.1648
23 BLOOD MAGNESIUM INCREASED 132 0.1463
24 ADJUSTMENT DISORDER 183 0.1408
25 RHEUMATIC FEVER 612 0.1372
26 HELICOBACTER INFECTION 1407 0.1368
27 RHEUMATOID FACTOR POSITIVE 781 0.1351
28 RETINITIS 209 0.1209
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 127 0.1196
30 HAND DEFORMITY 1559 0.1187
31 C-REACTIVE PROTEIN ABNORMAL 742 0.1156
32 PEMPHIGUS 1430 0.1143
33 NEPHROGENIC ANAEMIA 516 0.1113
34 HYPERPARATHYROIDISM SECONDARY 278 0.1108
35 FACET JOINT SYNDROME 361 0.1108
36 PERIPHERAL VENOUS DISEASE 421 0.1030
37 BLOOD PRESSURE DIASTOLIC DECREASED 747 0.1011
38 SYNOVITIS 1822 0.1009
39 BRONCHIAL SECRETION RETENTION 128 0.1005
40 BLOOD PRESSURE DIASTOLIC INCREASED 463 0.1002
41 IRRITABLE BOWEL SYNDROME 2120 0.0988
42 BLOOD PRESSURE SYSTOLIC INCREASED 1892 0.0969
43 BURSITIS 1166 0.0960
44 PERSONALITY DISORDER 237 0.0904
45 PERICARDITIS 1469 0.0873
46 BONE EROSION 297 0.0839
47 FOOD ALLERGY 634 0.0821
48 REBOUND ACID HYPERSECRETION 242 0.0799
49 PORPHYRIA ACUTE 114 0.0794
50 MATERNAL EXPOSURE TIMING UNSPECIFIED 294 0.0782
51 BLOOD PRESSURE FLUCTUATION 1851 0.0770
52 OSTEOSCLEROSIS 118 0.0749
53 INFUSION RELATED REACTION 4966 0.0748
54 ESSENTIAL HYPERTENSION 128 0.0699
55 GLOSSODYNIA 1543 0.0689
56 MUSCLE SPASTICITY 825 0.0671
57 IMPAIRED HEALING 2202 0.0670
58 CONTRAINDICATED PRODUCT ADMINISTERED 2002 0.0661
59 JOINT RANGE OF MOTION DECREASED 878 0.0654
60 EXPOSURE DURING PREGNANCY 4052 0.0651
61 LIP DRY 590 0.0649
62 WOUND 1768 0.0632
63 LOWER RESPIRATORY TRACT INFECTION 2826 0.0621
64 WHITE BLOOD CELLS URINE POSITIVE 114 0.0605
65 EAR PAIN 1163 0.0598
66 END STAGE RENAL DISEASE 1060 0.0581
67 AUTOIMMUNE DISORDER 563 0.0577
68 DEAFNESS NEUROSENSORY 188 0.0571
69 GRIP STRENGTH DECREASED 497 0.0564
70 INFUSION SITE PRURITUS 176 0.0557
71 BODY TEMPERATURE INCREASED 1133 0.0555
72 INFUSION SITE BRUISING 118 0.0546
73 EXOSTOSIS 496 0.0543
74 RED CELL DISTRIBUTION WIDTH INCREASED 223 0.0536
75 PUSTULAR PSORIASIS 182 0.0529
76 BODY TEMPERATURE DECREASED 521 0.0529
77 WOUND INFECTION 578 0.0527
78 WALKING AID USER 345 0.0523
79 URINE ABNORMALITY 235 0.0516
80 SCIATICA 822 0.0515
81 EPIGASTRIC DISCOMFORT 201 0.0514
82 INFUSION SITE HAEMORRHAGE 169 0.0513
83 IMMUNODEFICIENCY 750 0.0503
84 FOETAL DEATH 260 0.0501
85 INFUSION SITE SWELLING 310 0.0492
86 FIBROMYALGIA 1180 0.0485
87 PRESCRIBED OVERDOSE 908 0.0469
88 SYSTEMIC LUPUS ERYTHEMATOSUS 1661 0.0468
89 ARTHROPATHY 2588 0.0465
90 EAR PRURITUS 163 0.0464
91 HYPERCHOLESTEROLAEMIA 448 0.0464
92 HEART RATE DECREASED 1619 0.0461
93 NIGHT SWEATS 1479 0.0459
94 SCOLIOSIS 282 0.0455
95 BREAST CANCER STAGE III 294 0.0453
96 OSTEOARTHRITIS 1918 0.0452
97 BLISTER 2537 0.0451
98 THERAPEUTIC PRODUCT EFFECT DECREASED 2023 0.0451
99 CHRONIC KIDNEY DISEASE 3427 0.0451
100 INFUSION SITE ERYTHEMA 379 0.0449
101 RASH VESICULAR 216 0.0446
102 SINUSITIS 4518 0.0440
103 STOMATITIS 2660 0.0438
104 JOINT SWELLING 5255 0.0435
105 POOR VENOUS ACCESS 449 0.0433
106 COELIAC DISEASE 424 0.0432
107 INFUSION SITE PAIN 551 0.0427
108 HEPATIC ENZYME INCREASED 2912 0.0427
109 ATELECTASIS 409 0.0423
110 LOWER LIMB FRACTURE 811 0.0422
111 LIVE BIRTH 349 0.0417
112 SPINAL STENOSIS 171 0.0414
113 ATTENTION DEFICIT HYPERACTIVITY DISORDER 174 0.0413
114 FINGER DEFORMITY 200 0.0412
115 RED BLOOD CELL SEDIMENTATION RATE INCREASED 453 0.0409
116 RHEUMATOID ARTHRITIS 4627 0.0407
117 SINUS CONGESTION 548 0.0405
118 OXYGEN SATURATION DECREASED 2267 0.0403
119 GANGRENE 243 0.0403
120 ARTHRITIS INFECTIVE 187 0.0403
121 WEIGHT FLUCTUATION 418 0.0399
122 INFUSION SITE REACTION 116 0.0388
123 BREAST CANCER STAGE II 319 0.0383
124 LIVER INJURY 936 0.0381
125 ILL-DEFINED DISORDER 2285 0.0376
126 PULMONARY FIBROSIS 716 0.0373
127 FIBROSIS 114 0.0370
128 ARTERIAL OCCLUSIVE DISEASE 290 0.0369
129 SPINAL OSTEOARTHRITIS 324 0.0368
130 PERIPHERAL SWELLING 5654 0.0367
131 SENSORY LOSS 292 0.0362
132 HIP ARTHROPLASTY 554 0.0361
133 RESPIRATORY RATE INCREASED 320 0.0360
134 GAIT INABILITY 1202 0.0359
135 INTERVERTEBRAL DISC DEGENERATION 332 0.0358
136 SPUTUM DISCOLOURED 340 0.0358
137 GASTROINTESTINAL DISORDER 3188 0.0356
138 CONTUSION 3407 0.0354
139 SINUS DISORDER 699 0.0353
140 SEASONAL ALLERGY 498 0.0351
141 DISCOMFORT 2146 0.0351
142 JOINT EFFUSION 240 0.0348
143 DYSLIPIDAEMIA 176 0.0346
144 SWELLING 3242 0.0346
145 DRUG INTOLERANCE 3314 0.0343
146 OSTEOPENIA 515 0.0339
147 NERVE COMPRESSION 309 0.0334
148 RESPIRATORY DISORDER 999 0.0334
149 OBESITY 532 0.0334
150 FOOT DEFORMITY 369 0.0333
151 UPPER-AIRWAY COUGH SYNDROME 269 0.0326
152 PSORIATIC ARTHROPATHY 1322 0.0325
153 FAILURE TO THRIVE 169 0.0325
154 RESPIRATORY TRACT CONGESTION 514 0.0323
155 MUSCULOSKELETAL STIFFNESS 2795 0.0319
156 MUSCULOSKELETAL PAIN 1656 0.0316
157 NASOPHARYNGITIS 5785 0.0314
158 UPPER RESPIRATORY TRACT INFECTION 1449 0.0313
159 HAEMOGLOBIN INCREASED 143 0.0313
160 INTENTIONAL PRODUCT USE ISSUE 2736 0.0312
161 PROTEIN URINE PRESENT 155 0.0311
162 BLOOD PRESSURE SYSTOLIC DECREASED 141 0.0310
163 MULTIPLE ALLERGIES 243 0.0310
164 TYPE 2 DIABETES MELLITUS 1034 0.0307
165 BRONCHIECTASIS 205 0.0304
166 BLOOD PRESSURE INCREASED 4648 0.0304
167 JOINT DISLOCATION 315 0.0298
168 INFUSION SITE EXTRAVASATION 184 0.0295
169 CYST 366 0.0295
170 JOINT STIFFNESS 770 0.0293
171 CONCUSSION 227 0.0293
172 HEMIPLEGIA 242 0.0291
173 BLOOD MAGNESIUM DECREASED 251 0.0291
174 ULCER HAEMORRHAGE 195 0.0288
175 LIGAMENT SPRAIN 284 0.0287
176 TENDERNESS 299 0.0287
177 PRODUCTIVE COUGH 1368 0.0286
178 THERAPEUTIC PRODUCT EFFECT VARIABLE 111 0.0286
179 BACK DISORDER 465 0.0286
180 KNEE ARTHROPLASTY 602 0.0286
181 SARS-COV-2 TEST POSITIVE 377 0.0285
182 OBSTRUCTION 114 0.0285
183 IRON DEFICIENCY 128 0.0284
184 APHTHOUS ULCER 219 0.0282
185 SYNOVIAL CYST 130 0.0281
186 RIB FRACTURE 576 0.0280
187 BLOOD CHOLESTEROL INCREASED 1305 0.0280
188 LUPUS-LIKE SYNDROME 252 0.0278
189 BODY HEIGHT DECREASED 297 0.0277
190 EAR INFECTION 739 0.0277
191 TOOTH INFECTION 365 0.0277
192 MOTOR DYSFUNCTION 282 0.0276
193 FLUID RETENTION 1403 0.0276
194 CYSTITIS 878 0.0275
195 WHEEZING 1626 0.0274
196 FULL BLOOD COUNT ABNORMAL 290 0.0274
197 OSTEOPOROSIS 1125 0.0273
198 LIVER DISORDER 1211 0.0273
199 NECK PAIN 1526 0.0273
200 SKIN ABRASION 129 0.0273
201 MUSCULOSKELETAL CHEST PAIN 421 0.0272
202 RALES 157 0.0270
203 INCORRECT DRUG ADMINISTRATION RATE 115 0.0270
204 ARTHRITIS 2122 0.0269
205 VITAMIN D DEFICIENCY 263 0.0269
206 INCREASED TENDENCY TO BRUISE 248 0.0269
207 INFECTION 3882 0.0268
208 PULMONARY MASS 399 0.0268
209 BACK PAIN 6210 0.0267
210 PULMONARY FUNCTION TEST DECREASED 117 0.0267
211 RHINORRHOEA 1723 0.0266
212 THROAT IRRITATION 1189 0.0265
213 TOOTH ABSCESS 269 0.0264
214 NEURALGIA 638 0.0262
215 HEART RATE INCREASED 2599 0.0262
216 APPETITE DISORDER 173 0.0261
217 SLEEP DISORDER 1841 0.0261
218 ORAL PAIN 583 0.0260
219 MYOSITIS 233 0.0259
220 DENTAL CARIES 287 0.0259
221 DYSPNOEA EXERTIONAL 977 0.0259
222 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1841 0.0259
223 MOBILITY DECREASED 1853 0.0258
224 ABDOMINAL DISCOMFORT 4322 0.0257
225 TOOTH DISORDER 571 0.0257
226 SKIN LACERATION 279 0.0256
227 SINUS HEADACHE 152 0.0256
228 OEDEMA 1384 0.0255
229 BLOOD IRON DECREASED 302 0.0254
230 HAEMATOCRIT DECREASED 504 0.0254
231 PSYCHOLOGICAL TRAUMA 219 0.0253
232 TASTE DISORDER 513 0.0253
233 HIATUS HERNIA 327 0.0252
234 ARTHRALGIA 10474 0.0252
235 NEPHROLITHIASIS 1147 0.0250
236 GASTROOESOPHAGEAL REFLUX DISEASE 2002 0.0248
237 HOSPICE CARE 245 0.0248
238 SNEEZING 556 0.0248
239 OROPHARYNGEAL PAIN 2294 0.0248
240 NASAL CONGESTION 1456 0.0248
241 AFFECT LABILITY 237 0.0246
242 VIRAL UPPER RESPIRATORY TRACT INFECTION 117 0.0246
243 RENAL CYST 195 0.0245
244 LYMPHOCYTE COUNT DECREASED 434 0.0245
245 TOOTHACHE 444 0.0245
246 TRICUSPID VALVE INCOMPETENCE 194 0.0244
247 MUSCULOSKELETAL DISCOMFORT 420 0.0244
248 MUSCLE STRAIN 211 0.0244
249 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1168 0.0243
250 PAIN IN JAW 686 0.0242
251 LIMB INJURY 655 0.0241
252 RED BLOOD CELL COUNT DECREASED 689 0.0241
253 EATING DISORDER 513 0.0241
254 EAR DISORDER 110 0.0240
255 VITAMIN D DECREASED 205 0.0240
256 UMBILICAL HERNIA 112 0.0239
257 WEIGHT INCREASED 5362 0.0239
258 SKIN ATROPHY 137 0.0238
259 ROTATOR CUFF SYNDROME 305 0.0237
260 HYPERSENSITIVITY 4407 0.0237
261 FLANK PAIN 222 0.0237
262 BACK INJURY 257 0.0236
263 GENERAL SYMPTOM 177 0.0236
264 NEPHROPATHY 220 0.0235
265 FEELING OF BODY TEMPERATURE CHANGE 138 0.0235
266 THERAPY NON-RESPONDER 1058 0.0235
267 MASS 328 0.0234
268 MIGRAINE 2240 0.0234
269 CONFUSIONAL STATE 3782 0.0234
270 CHILLS 2743 0.0234
271 HYPERKERATOSIS 129 0.0234
272 PRODUCT ADMINISTRATION INTERRUPTED 183 0.0233
273 COORDINATION ABNORMAL 324 0.0232
274 SKIN HAEMORRHAGE 344 0.0232
275 INFLAMMATION 1192 0.0231
276 LOCALISED INFECTION 557 0.0230
277 SEDATION 601 0.0229
278 PREGNANCY 458 0.0228
279 NODULE 298 0.0228
280 LUNG DISORDER 1117 0.0228
281 POOR QUALITY SLEEP 490 0.0227
282 NEUTROPHIL COUNT INCREASED 233 0.0227
283 ROAD TRAFFIC ACCIDENT 950 0.0227
284 HEPATIC CIRRHOSIS 426 0.0226
285 SMALL INTESTINAL OBSTRUCTION 279 0.0226
286 SPINAL COMPRESSION FRACTURE 187 0.0226
287 HAEMORRHOIDS 440 0.0225
288 DECREASED INTEREST 133 0.0225
289 RENAL INJURY 668 0.0225
290 HEART RATE IRREGULAR 508 0.0225
291 ACUTE RESPIRATORY FAILURE 432 0.0224
292 POLYP 147 0.0224
293 DIVERTICULITIS 622 0.0224
294 UTERINE LEIOMYOMA 164 0.0224
295 MITRAL VALVE INCOMPETENCE 253 0.0223
296 BLOOD URINE PRESENT 424 0.0223
297 DYSPEPSIA 2196 0.0223
298 BREATH SOUNDS ABNORMAL 110 0.0223
299 OBSTRUCTIVE AIRWAYS DISORDER 248 0.0223
300 ANAL FISSURE 119 0.0222
301 PYREXIA 7646 0.0221
302 HEADACHE 13723 0.0219
303 VARICOSE VEIN 113 0.0219
304 DRY MOUTH 1775 0.0219
305 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 375 0.0219
306 PAIN IN EXTREMITY 6431 0.0218
307 PAIN 13406 0.0218
308 SPINAL PAIN 255 0.0217
309 FREQUENT BOWEL MOVEMENTS 586 0.0217
310 BLOOD POTASSIUM DECREASED 651 0.0216
311 LOWER GASTROINTESTINAL HAEMORRHAGE 160 0.0216
312 CHEST DISCOMFORT 2216 0.0216
313 FATIGUE 16835 0.0216
314 PRESCRIBED UNDERDOSE 429 0.0215
315 SKIN WARM 125 0.0215
316 HAND FRACTURE 152 0.0214
317 ECCHYMOSIS 147 0.0214
318 FULL BLOOD COUNT DECREASED 432 0.0214
319 TOOTH FRACTURE 236 0.0214
320 ANKYLOSING SPONDYLITIS 282 0.0214
321 CARDIAC MURMUR 185 0.0214
322 NAIL DISORDER 187 0.0214
323 COUGH 5979 0.0213
324 CONSTIPATION 4647 0.0213
325 BLOOD COUNT ABNORMAL 323 0.0213
326 DIVERTICULUM 151 0.0212
327 CARDIOMEGALY 261 0.0212
328 IMPAIRED GASTRIC EMPTYING 289 0.0212
329 HYPERTENSION 4480 0.0211
330 ABDOMINAL PAIN UPPER 4349 0.0211
331 KIDNEY INFECTION 413 0.0210
332 OVERWEIGHT 113 0.0210
333 DECUBITUS ULCER 171 0.0210
334 GINGIVAL PAIN 167 0.0210
335 SLEEP APNOEA SYNDROME 400 0.0209
336 BRONCHITIS 1551 0.0209
337 HYPOAESTHESIA 3132 0.0209
338 BRAIN FOG 327 0.0208
339 RENAL PAIN 221 0.0208
340 GASTROENTERITIS VIRAL 376 0.0208
341 MENISCUS INJURY 128 0.0208
342 GOUT 373 0.0208
343 NIGHTMARE 716 0.0207
344 HEMIPARESIS 350 0.0206
345 FEELING HOT 1266 0.0206
346 ASTHMA 2332 0.0206
347 CATARACT 1226 0.0206
348 LIMB DISCOMFORT 637 0.0206
349 URINARY TRACT INFECTION 3500 0.0205
350 HYPERLIPIDAEMIA 245 0.0205
351 FACIAL PAIN 183 0.0205
352 HYPERHIDROSIS 2624 0.0203
353 URTICARIA 3410 0.0203
354 MIDDLE INSOMNIA 380 0.0203
355 SKIN LESION 558 0.0203
356 CLOSTRIDIUM DIFFICILE INFECTION 444 0.0203
357 INTERVERTEBRAL DISC PROTRUSION 444 0.0203
358 DRUG LEVEL BELOW THERAPEUTIC 112 0.0203
359 EAR DISCOMFORT 208 0.0202
360 FEELING COLD 564 0.0202
361 TREATMENT FAILURE 1676 0.0202
362 PROCTALGIA 130 0.0202
363 WEIGHT DECREASED 5636 0.0202
364 BLEPHAROSPASM 127 0.0201
365 CHEST PAIN 3717 0.0200
366 RASH ERYTHEMATOUS 959 0.0200
367 MATERNAL EXPOSURE BEFORE PREGNANCY 137 0.0200
368 ONYCHOCLASIS 138 0.0200
369 HEAD DISCOMFORT 355 0.0200
370 PHARYNGITIS STREPTOCOCCAL 217 0.0200
371 ASTHENIA 7530 0.0200
372 MALNUTRITION 224 0.0200
373 LYMPHOEDEMA 138 0.0199
374 MUSCULAR WEAKNESS 2265 0.0199
375 EYE INFECTION 225 0.0199
376 ORAL CANDIDIASIS 262 0.0199
377 JOINT INJURY 424 0.0198
378 INFLUENZA 2212 0.0198
379 PHARYNGEAL SWELLING 194 0.0198
380 POST PROCEDURAL INFECTION 161 0.0198
381 BLOOD PRESSURE ABNORMAL 393 0.0197
382 DERMATITIS CONTACT 225 0.0197
383 PHOTOPHOBIA 371 0.0197
384 ATRIAL SEPTAL DEFECT 165 0.0197
385 HEPATIC STEATOSIS 366 0.0196
386 THERAPEUTIC RESPONSE UNEXPECTED 880 0.0196
387 RETCHING 417 0.0195
388 DECREASED ACTIVITY 211 0.0195
389 BLOOD POTASSIUM INCREASED 317 0.0195
390 SKIN INFECTION 219 0.0195
391 TROPONIN INCREASED 148 0.0194
392 CARPAL TUNNEL SYNDROME 272 0.0194
393 RENAL FAILURE 2578 0.0194
394 GAIT DISTURBANCE 3714 0.0194
395 URINE ODOUR ABNORMAL 114 0.0194
396 BLOOD TEST ABNORMAL 272 0.0193
397 DELIRIUM 670 0.0193
398 DRY THROAT 196 0.0193
399 BONE PAIN 1125 0.0192
400 RENAL TUBULAR NECROSIS 188 0.0191
401 DYSSTASIA 559 0.0191
402 ODYNOPHAGIA 114 0.0191
403 EOSINOPHIL COUNT INCREASED 159 0.0191
404 FOOT FRACTURE 361 0.0190
405 IMPAIRED QUALITY OF LIFE 272 0.0189
406 LARGE INTESTINE POLYP 131 0.0189
407 MICTURITION URGENCY 216 0.0189
408 ABSCESS 301 0.0188
409 RESTLESS LEGS SYNDROME 343 0.0188
410 DEFAECATION URGENCY 132 0.0188
411 FRUSTRATION TOLERANCE DECREASED 152 0.0188
412 FOETAL EXPOSURE DURING PREGNANCY 1528 0.0188
413 WRIST FRACTURE 225 0.0188
414 FISTULA 211 0.0188
415 DECREASED APPETITE 4357 0.0187
416 IRON DEFICIENCY ANAEMIA 173 0.0187
417 INFLUENZA LIKE ILLNESS 1540 0.0187
418 ACUTE KIDNEY INJURY 2859 0.0187
419 ANAL INCONTINENCE 168 0.0187
420 INSOMNIA 4965 0.0186
421 DISABILITY 368 0.0186
422 TUBULOINTERSTITIAL NEPHRITIS 348 0.0185
423 OSTEOMYELITIS 336 0.0185
424 HYPOKINESIA 269 0.0185
425 ALOPECIA 3637 0.0185
426 DYSURIA 681 0.0185
427 BOWEL MOVEMENT IRREGULARITY 141 0.0184
428 BONE DISORDER 335 0.0184
429 GALLBLADDER DISORDER 328 0.0184
430 DIZZINESS POSTURAL 178 0.0183
431 SPLENOMEGALY 215 0.0183
432 BLOOD CALCIUM DECREASED 206 0.0183
433 ORAL DISORDER 134 0.0183
434 VIRAL INFECTION 608 0.0183
435 PULMONARY THROMBOSIS 199 0.0182
436 CELLULITIS 919 0.0182
437 PERIPHERAL COLDNESS 250 0.0182
438 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 309 0.0182
439 PNEUMONIA 5883 0.0182
440 HERPES ZOSTER 1044 0.0182
441 DYSPNOEA 10278 0.0181
442 MUSCLE SPASMS 3327 0.0181
443 COVID-19 3177 0.0181
444 GROIN PAIN 159 0.0181
445 RECTAL HAEMORRHAGE 776 0.0180
446 EMPHYSEMA 182 0.0180
447 APHONIA 251 0.0180
448 PELVIC FRACTURE 140 0.0180
449 INCONTINENCE 190 0.0180
450 ARTHROPOD BITE 133 0.0179
451 GINGIVAL BLEEDING 245 0.0179
452 IMMUNOSUPPRESSION 158 0.0179
453 INJURY 1259 0.0179
454 BLOOD ALBUMIN DECREASED 142 0.0179
455 HAEMOGLOBIN DECREASED 1836 0.0179
456 FAECES SOFT 130 0.0179
457 HOT FLUSH 1347 0.0179
458 SPINAL DISORDER 169 0.0178
459 HYPERSOMNIA 511 0.0178
460 PRURITUS 6844 0.0178
461 SECRETION DISCHARGE 223 0.0178
462 FALL 5917 0.0178
463 MUSCLE ATROPHY 225 0.0177
464 ORAL HERPES 346 0.0177
465 BLADDER DISORDER 176 0.0177
466 MATERNAL EXPOSURE DURING PREGNANCY 1579 0.0177
467 PRODUCT USE ISSUE 3328 0.0177
468 RESPIRATORY TRACT INFECTION 461 0.0177
469 WHITE BLOOD CELL COUNT INCREASED 679 0.0177
470 DIARRHOEA 11382 0.0176
471 POSTOPERATIVE WOUND INFECTION 119 0.0176
472 NEUROPATHY PERIPHERAL 1670 0.0175
473 RASH 7651 0.0175
474 DRY EYE 875 0.0175
475 AMNESIA 1138 0.0175
476 OROPHARYNGEAL DISCOMFORT 158 0.0175
477 RHINITIS 141 0.0175
478 C-REACTIVE PROTEIN INCREASED 636 0.0175
479 THERAPEUTIC RESPONSE SHORTENED 579 0.0174
480 GASTROINTESTINAL PAIN 192 0.0174
481 THROAT TIGHTNESS 472 0.0174
482 ILLNESS 1797 0.0174
483 TENDONITIS 270 0.0174
484 FLUSHING 1770 0.0174
485 HAIR COLOUR CHANGES 216 0.0173
486 POST-TRAUMATIC STRESS DISORDER 116 0.0173
487 URINARY INCONTINENCE 512 0.0173
488 HAEMATOCHEZIA 953 0.0173
489 SCRATCH 182 0.0172
490 ABDOMINAL PAIN 4009 0.0172
491 DEFORMITY 161 0.0172
492 LUNG INFILTRATION 152 0.0172
493 HYPOAESTHESIA ORAL 258 0.0171
494 HIP FRACTURE 550 0.0171
495 EPISTAXIS 1279 0.0171
496 BALANCE DISORDER 1474 0.0170
497 MUSCLE TIGHTNESS 276 0.0170
498 BLOOD SODIUM DECREASED 321 0.0170
499 APHASIA 513 0.0170
500 HEAD INJURY 535 0.0169
501 NAUSEA 13374 0.0169
502 NOCTURIA 205 0.0169
503 OEDEMA PERIPHERAL 2047 0.0168
504 HYPOXIA 590 0.0167
505 OCULAR DISCOMFORT 188 0.0167
506 FAECES DISCOLOURED 363 0.0167
507 ACUTE HEPATIC FAILURE 228 0.0167
508 GLOMERULAR FILTRATION RATE DECREASED 205 0.0167
509 LYMPHADENOPATHY 589 0.0166
510 GASTRIC DISORDER 571 0.0166
511 LABORATORY TEST ABNORMAL 491 0.0166
512 DEHYDRATION 2217 0.0166
513 TEMPERATURE INTOLERANCE 171 0.0166
514 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 864 0.0165
515 ATRIAL FLUTTER 132 0.0165
516 PHARYNGITIS 205 0.0165
517 HAIR DISORDER 136 0.0165
518 HERNIA 319 0.0165
519 VOMITING 7741 0.0164
520 PLATELET COUNT INCREASED 214 0.0164
521 SKIN ULCER 424 0.0164
522 BLOOD PRESSURE DECREASED 1089 0.0164
523 PULMONARY CONGESTION 216 0.0164
524 ANXIETY 4661 0.0164
525 PARAESTHESIA 2564 0.0163
526 MOVEMENT DISORDER 523 0.0163
527 FURUNCLE 129 0.0163
528 SPINAL FRACTURE 326 0.0163
529 DYSPHONIA 947 0.0162
530 DYSPHAGIA 1534 0.0161
531 POLLAKIURIA 671 0.0161
532 WHITE BLOOD CELL COUNT DECREASED 1744 0.0161
533 MYALGIA 2735 0.0161
534 ATRIAL FIBRILLATION 1561 0.0160
535 ANGINA PECTORIS 459 0.0160
536 CEREBRAL DISORDER 118 0.0159
537 PALPITATIONS 1868 0.0159
538 UROSEPSIS 147 0.0159
539 VASCULITIS 185 0.0159
540 MENTAL STATUS CHANGES 441 0.0159
541 MUSCULOSKELETAL DISORDER 302 0.0159
542 MEMORY IMPAIRMENT 2179 0.0158
543 RESPIRATORY SYNCYTIAL VIRUS INFECTION 138 0.0158
544 PLEURAL EFFUSION 964 0.0158
545 GLAUCOMA 305 0.0158
546 CHOLELITHIASIS 518 0.0158
547 ULCER 251 0.0158
548 CONGENITAL ANOMALY 122 0.0157
549 EYE PAIN 889 0.0157
550 HEREDITARY ANGIOEDEMA 169 0.0157
551 FLATULENCE 893 0.0157
552 GENERALISED OEDEMA 194 0.0157
553 PRODUCT USE IN UNAPPROVED INDICATION 3880 0.0156
554 HYPOPHAGIA 400 0.0156
555 LACERATION 147 0.0156
556 HAIR TEXTURE ABNORMAL 209 0.0156
557 PARAESTHESIA ORAL 225 0.0156
558 FEEDING DISORDER 316 0.0156
559 THYROID DISORDER 240 0.0156
560 CLOSTRIDIUM DIFFICILE COLITIS 165 0.0155
561 LIVER FUNCTION TEST INCREASED 334 0.0155
562 SCAB 177 0.0155
563 COLITIS 588 0.0155
564 BREAST PAIN 165 0.0155
565 SKIN DISCOLOURATION 711 0.0155
566 SKIN DISORDER 514 0.0154
567 DIZZINESS 7628 0.0153
568 HYDRONEPHROSIS 114 0.0152
569 ABDOMINAL DISTENSION 1585 0.0152
570 AGEUSIA 378 0.0151
571 NERVE INJURY 168 0.0151
572 DEPRESSION 3436 0.0151
573 CANDIDA INFECTION 255 0.0151
574 DECREASED IMMUNE RESPONSIVENESS 148 0.0151
575 INTERNAL HAEMORRHAGE 172 0.0150
576 UPPER GASTROINTESTINAL HAEMORRHAGE 253 0.0150
577 GASTRITIS 395 0.0150
578 COVID-19 PNEUMONIA 177 0.0150
579 FUNGAL INFECTION 495 0.0148
580 PAROSMIA 112 0.0148
581 UPPER LIMB FRACTURE 295 0.0148
582 PULMONARY HYPERTENSION 308 0.0148
583 COAGULOPATHY 246 0.0147
584 DYSARTHRIA 555 0.0147
585 PLATELET COUNT DECREASED 1569 0.0147
586 BACTERIAL INFECTION 274 0.0147
587 POST PROCEDURAL COMPLICATION 282 0.0147
588 BEDRIDDEN 193 0.0147
589 ABNORMAL FAECES 120 0.0146
590 PERICARDIAL EFFUSION 338 0.0146
591 BASAL CELL CARCINOMA 228 0.0146
592 HEPATIC FAILURE 440 0.0146
593 BLOOD CREATININE INCREASED 952 0.0146
594 ORAL DISCOMFORT 202 0.0145
595 UVEITIS 197 0.0145
596 SUPRAVENTRICULAR TACHYCARDIA 139 0.0145
597 BLOOD UREA INCREASED 243 0.0145
598 OVARIAN CYST 145 0.0145
599 NASAL DISCOMFORT 115 0.0145
600 GENERAL PHYSICAL HEALTH DETERIORATION 1678 0.0145
601 AORTIC ANEURYSM 110 0.0144
602 URINE OUTPUT DECREASED 126 0.0144
603 LETHARGY 828 0.0144
604 TINNITUS 661 0.0144
605 OFF LABEL USE 12585 0.0144
606 SCAR 246 0.0144
607 HYPERAESTHESIA 118 0.0143
608 MALAISE 6292 0.0143
609 SOMNOLENCE 2885 0.0143
610 INTESTINAL OBSTRUCTION 540 0.0143
611 GASTROINTESTINAL INFECTION 128 0.0143
612 FEELING JITTERY 272 0.0143
613 STAPHYLOCOCCAL INFECTION 470 0.0142
614 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2563 0.0142
615 INTENTIONAL DOSE OMISSION 405 0.0142
616 TACHYCARDIA 1262 0.0142
617 MUSCLE DISORDER 115 0.0142
618 RENAL DISORDER 660 0.0142
619 CONDITION AGGRAVATED 4304 0.0141
620 MADAROSIS 164 0.0141
621 MYASTHENIA GRAVIS 114 0.0141
622 LEUKOCYTOSIS 255 0.0141
623 ANKLE FRACTURE 218 0.0141
624 PRODUCT USE COMPLAINT 221 0.0140
625 HALLUCINATION 1057 0.0140
626 RASH PRURITIC 760 0.0140
627 INJECTION SITE EXTRAVASATION 173 0.0140
628 DYSGEUSIA 1040 0.0140
629 PHOTOSENSITIVITY REACTION 231 0.0140
630 PRODUCT DOSE OMISSION IN ERROR 396 0.0140
631 GASTROENTERITIS 204 0.0140
632 INITIAL INSOMNIA 143 0.0139
633 HYPOTENSION 2791 0.0139
634 HAEMOPTYSIS 387 0.0139
635 SKIN FISSURES 271 0.0139
636 PRESYNCOPE 337 0.0138
637 MOUTH ULCERATION 292 0.0138
638 PULMONARY OEDEMA 620 0.0138
639 GASTRIC ULCER 263 0.0138
640 FEELING ABNORMAL 3312 0.0138
641 BURNING SENSATION 967 0.0138
642 PALLOR 375 0.0138
643 LACRIMATION INCREASED 416 0.0138
644 PRODUCT ADMINISTRATION ERROR 278 0.0137
645 PNEUMOTHORAX 218 0.0137
646 TRANSFUSION 144 0.0137
647 IMMUNE SYSTEM DISORDER 181 0.0137
648 SPINAL OPERATION 169 0.0137
649 ADVERSE EVENT 1264 0.0137
650 SENSATION OF FOREIGN BODY 115 0.0136
651 GASTROINTESTINAL HAEMORRHAGE 1135 0.0136
652 TREMOR 2250 0.0135
653 THIRST 242 0.0135
654 PNEUMONIA BACTERIAL 124 0.0135
655 ARTERIOSCLEROSIS 127 0.0135
656 SLUGGISHNESS 137 0.0134
657 PROCEDURAL PAIN 372 0.0134
658 FACIAL PARALYSIS 114 0.0134
659 SEPSIS 1488 0.0133
660 BLOOD ALKALINE PHOSPHATASE INCREASED 331 0.0133
661 DRUG INEFFECTIVE 17470 0.0132
662 ABDOMINAL PAIN LOWER 335 0.0132
663 COLITIS ULCERATIVE 590 0.0132
664 CHOLECYSTITIS 157 0.0132
665 MUSCLE TWITCHING 303 0.0131
666 TRANSIENT ISCHAEMIC ATTACK 442 0.0131
667 DRUG LEVEL DECREASED 133 0.0131
668 EYE SWELLING 486 0.0131
669 COLD SWEAT 230 0.0130
670 ADRENAL INSUFFICIENCY 158 0.0130
671 EYE INFLAMMATION 124 0.0130
672 BACTERAEMIA 154 0.0130
673 INTENTIONAL PRODUCT MISUSE 1136 0.0130
674 TENDON RUPTURE 160 0.0129
675 IMPAIRED WORK ABILITY 277 0.0129
676 DIPLOPIA 336 0.0129
677 THROMBOSIS 1040 0.0129
678 BRONCHOSPASM 184 0.0129
679 SINUS TACHYCARDIA 183 0.0129
680 SPEECH DISORDER 675 0.0129
681 TOOTH EXTRACTION 160 0.0128
682 ANAEMIA 2450 0.0128
683 HEPATOMEGALY 126 0.0128
684 DEEP VEIN THROMBOSIS 832 0.0128
685 THINKING ABNORMAL 238 0.0128
686 RASH MACULAR 444 0.0127
687 ASPIRATION 139 0.0127
688 INTESTINAL PERFORATION 142 0.0126
689 CHROMATURIA 284 0.0126
690 ERYTHEMA 2585 0.0126
691 BRAIN OEDEMA 158 0.0125
692 BRAIN INJURY 125 0.0125
693 DISEASE RECURRENCE 592 0.0124
694 PSORIASIS 1620 0.0124
695 PRODUCT DISTRIBUTION ISSUE 115 0.0124
696 VERTIGO 755 0.0124
697 CARDIAC FAILURE CONGESTIVE 993 0.0123
698 INSURANCE ISSUE 189 0.0123
699 SKIN CANCER 266 0.0123
700 EYE DISORDER 406 0.0123
701 VISION BLURRED 1694 0.0123
702 SUBDURAL HAEMATOMA 176 0.0123
703 LUNG INFECTION 191 0.0123
704 CRYING 446 0.0123
705 INCREASED APPETITE 234 0.0122
706 ELECTROLYTE IMBALANCE 142 0.0122
707 ADVERSE DRUG REACTION 1097 0.0122
708 NERVOUSNESS 636 0.0122
709 NEUTROPHIL COUNT DECREASED 496 0.0122
710 ECONOMIC PROBLEM 184 0.0121
711 DEMENTIA 338 0.0121
712 MACULAR DEGENERATION 144 0.0120
713 EYE DISCHARGE 125 0.0120
714 PETECHIAE 125 0.0120
715 PANIC ATTACK 435 0.0119
716 SWELLING FACE 777 0.0119
717 VITREOUS FLOATERS 117 0.0119
718 SQUAMOUS CELL CARCINOMA 112 0.0119
719 CORONARY ARTERY OCCLUSION 163 0.0119
720 DIARRHOEA HAEMORRHAGIC 111 0.0119
721 HALLUCINATION, VISUAL 250 0.0118
722 QUALITY OF LIFE DECREASED 158 0.0118
723 LOCAL SWELLING 205 0.0117
724 HYPERCALCAEMIA 145 0.0117
725 VISUAL IMPAIRMENT 1455 0.0117
726 CHOKING 229 0.0117
727 OESOPHAGITIS 128 0.0117
728 CORONARY ARTERY DISEASE 354 0.0117
729 SENSORY DISTURBANCE 187 0.0116
730 HYPOKALAEMIA 535 0.0116
731 HAEMATURIA 396 0.0116
732 HYPOMAGNESAEMIA 161 0.0116
733 ACCIDENT 138 0.0115
734 VENTRICULAR EXTRASYSTOLES 120 0.0115
735 INFLAMMATORY BOWEL DISEASE 113 0.0115
736 PLASMA CELL MYELOMA 448 0.0115
737 LOSS OF CONSCIOUSNESS 1471 0.0115
738 CHOLECYSTECTOMY 131 0.0115
739 HYPOTHYROIDISM 366 0.0114
740 FLUID OVERLOAD 166 0.0114
741 METASTASES TO BONE 187 0.0114
742 FEBRILE NEUTROPENIA 755 0.0114
743 CONJUNCTIVITIS 211 0.0114
744 HYPOACUSIS 487 0.0113
745 ANAPHYLACTIC REACTION 625 0.0113
746 DEVICE RELATED INFECTION 174 0.0113
747 SYNCOPE 1130 0.0113
748 THERAPY PARTIAL RESPONDER 174 0.0111
749 PNEUMONIA ASPIRATION 277 0.0111
750 PULMONARY EMBOLISM 1050 0.0110
751 NEOPLASM 127 0.0110
752 TACHYPNOEA 150 0.0110
753 BLOOD BILIRUBIN INCREASED 297 0.0110
754 SKIN EXFOLIATION 924 0.0109
755 ALANINE AMINOTRANSFERASE INCREASED 671 0.0109
756 DIABETES MELLITUS 832 0.0109
757 DEAFNESS 285 0.0109
758 PNEUMONITIS 295 0.0108
759 MENTAL IMPAIRMENT 262 0.0108
760 UNRESPONSIVE TO STIMULI 278 0.0108
761 THROMBOCYTOPENIA 1198 0.0107
762 HUNGER 149 0.0107
763 INTERNATIONAL NORMALISED RATIO INCREASED 303 0.0106
764 DELUSION 165 0.0106
765 PANCREATITIS 559 0.0106
766 METASTASES TO LUNG 122 0.0105
767 ERUCTATION 204 0.0105
768 INCORRECT DOSE ADMINISTERED 2403 0.0105
769 PROSTATIC SPECIFIC ANTIGEN INCREASED 145 0.0105
770 RESPIRATORY FAILURE 767 0.0105
771 DRUG EFFECT INCOMPLETE 381 0.0105
772 PRODUCT DOSE OMISSION ISSUE 3083 0.0105
773 DEPRESSED MOOD 554 0.0105
774 MULTIPLE SCLEROSIS 499 0.0104
775 CARDIAC DISORDER 973 0.0104
776 DRUG EFFECT LESS THAN EXPECTED 154 0.0104
777 EYE PRURITUS 349 0.0104
778 COGNITIVE DISORDER 483 0.0103
779 FEMUR FRACTURE 320 0.0103
780 LIVER FUNCTION TEST ABNORMAL 300 0.0103
781 BLINDNESS UNILATERAL 145 0.0103
782 TOOTH LOSS 213 0.0103
783 MEDICATION ERROR 571 0.0103
784 EYE HAEMORRHAGE 137 0.0103
785 ANHEDONIA 269 0.0102
786 MALIGNANT MELANOMA 137 0.0102
787 ASCITES 300 0.0102
788 CENTRAL NERVOUS SYSTEM LESION 140 0.0102
789 MULTIPLE SCLEROSIS RELAPSE 698 0.0102
790 SKIN REACTION 143 0.0101
791 DRY SKIN 1355 0.0101
792 PARANOIA 175 0.0101
793 HAEMORRHAGE 1061 0.0101
794 BLOOD TRIGLYCERIDES INCREASED 179 0.0101
795 RENAL IMPAIRMENT 851 0.0101
796 HEPATITIS 259 0.0101
797 SWOLLEN TONGUE 316 0.0101
798 ASPARTATE AMINOTRANSFERASE INCREASED 536 0.0101
799 LIP SWELLING 336 0.0101
800 CARDIOMYOPATHY 149 0.0101
801 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 552 0.0100
802 RESPIRATORY DISTRESS 277 0.0100
803 HAEMATEMESIS 254 0.0100
804 THERAPY CESSATION 514 0.0100
805 DISTURBANCE IN ATTENTION 535 0.0099
806 ILEUS 123 0.0099
807 HAEMATOMA 253 0.0098
808 DISEASE PROGRESSION 1152 0.0097
809 DEVICE OCCLUSION 137 0.0097
810 CYANOSIS 152 0.0097
811 CEREBROVASCULAR ACCIDENT 1626 0.0096
812 DRUG-INDUCED LIVER INJURY 301 0.0096
813 URINARY RETENTION 320 0.0096
814 PRURITUS GENERALISED 207 0.0096
815 UNEVALUABLE EVENT 722 0.0095
816 BLOOD LACTATE DEHYDROGENASE INCREASED 151 0.0095
817 SEIZURE 1096 0.0095
818 PROTEINURIA 180 0.0095
819 MENTAL DISORDER 412 0.0095
820 FRACTURE 179 0.0094
821 IRRITABILITY 568 0.0094
822 RASH PAPULAR 210 0.0094
823 THERAPEUTIC RESPONSE DECREASED 566 0.0093
824 RESTLESSNESS 341 0.0093
825 PRODUCT DOSE OMISSION 604 0.0092
826 ENCEPHALOPATHY 227 0.0092
827 DERMATITIS 193 0.0092
828 NEOPLASM PROGRESSION 320 0.0092
829 ABASIA 227 0.0092
830 OCULAR HYPERAEMIA 436 0.0092
831 UNDERDOSE 667 0.0091
832 EJECTION FRACTION DECREASED 142 0.0091
833 ORTHOSTATIC HYPOTENSION 159 0.0091
834 DYSKINESIA 370 0.0091
835 PSYCHOMOTOR HYPERACTIVITY 151 0.0091
836 ACTIVITIES OF DAILY LIVING IMPAIRED 180 0.0091
837 PARALYSIS 130 0.0091
838 MULTIPLE FRACTURES 149 0.0091
839 CYTOPENIA 111 0.0091
840 ADVERSE REACTION 120 0.0090
841 METASTASES TO LIVER 159 0.0090
842 SURGERY 530 0.0090
843 DIABETES MELLITUS INADEQUATE CONTROL 160 0.0090
844 DISORIENTATION 356 0.0090
845 PAIN OF SKIN 241 0.0089
846 COLON CANCER 133 0.0089
847 BONE LOSS 134 0.0089
848 THERAPY INTERRUPTED 637 0.0089
849 MOOD SWINGS 284 0.0089
850 MOOD ALTERED 240 0.0088
851 ANGER 296 0.0087
852 EOSINOPHILIA 153 0.0087
853 HYPONATRAEMIA 491 0.0087
854 ACUTE MYOCARDIAL INFARCTION 255 0.0086
855 EXPIRED PRODUCT ADMINISTERED 287 0.0086
856 PULMONARY ARTERIAL HYPERTENSION 125 0.0086
857 COMPLICATION ASSOCIATED WITH DEVICE 125 0.0086
858 PHARYNGEAL OEDEMA 132 0.0086
859 BONE DENSITY DECREASED 268 0.0085
860 INTERSTITIAL LUNG DISEASE 414 0.0085
861 EYE IRRITATION 490 0.0085
862 INCORRECT PRODUCT ADMINISTRATION DURATION 184 0.0085
863 TREATMENT NONCOMPLIANCE 464 0.0085
864 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 197 0.0084
865 BRADYCARDIA 445 0.0084
866 PANCYTOPENIA 467 0.0083
867 OSTEONECROSIS OF JAW 205 0.0083
868 DRUG ADMINISTRATION ERROR 254 0.0083
869 PRODUCT PRESCRIBING ERROR 197 0.0083
870 OVERDOSE 1775 0.0082
871 AGITATION 603 0.0082
872 LYMPHOMA 126 0.0081
873 MYELODYSPLASTIC SYNDROME 117 0.0081
874 LEUKOPENIA 402 0.0080
875 INJECTION SITE BRUISING 641 0.0080
876 HOSPITALISATION 1234 0.0080
877 CEREBRAL HAEMORRHAGE 287 0.0080
878 HYPERGLYCAEMIA 292 0.0080
879 MALIGNANT NEOPLASM PROGRESSION 819 0.0080
880 PRODUCT AVAILABILITY ISSUE 182 0.0080
881 ARRHYTHMIA 377 0.0080
882 ACCIDENTAL OVERDOSE 291 0.0079
883 SEPTIC SHOCK 346 0.0079
884 MYOCARDIAL INFARCTION 1376 0.0079
885 ABNORMAL DREAMS 216 0.0078
886 ANAPHYLACTIC SHOCK 201 0.0078
887 EMOTIONAL DISORDER 239 0.0077
888 PELVIC PAIN 140 0.0077
889 ECZEMA 399 0.0076
890 JAUNDICE 205 0.0076
891 EXTRA DOSE ADMINISTERED 308 0.0076
892 FEAR 204 0.0076
893 RASH GENERALISED 196 0.0076
894 HAEMORRHAGE INTRACRANIAL 113 0.0075
895 PRODUCT PHYSICAL ISSUE 150 0.0074
896 ACNE 563 0.0074
897 RENAL FAILURE ACUTE 315 0.0074
898 SUICIDE ATTEMPT 448 0.0074
899 MENORRHAGIA 145 0.0074
900 EMOTIONAL DISTRESS 891 0.0074
901 NEUTROPENIA 985 0.0072
902 PREMATURE BABY 218 0.0072
903 INJECTION SITE RASH 222 0.0072
904 VAGINAL HAEMORRHAGE 314 0.0072
905 TRANSAMINASES INCREASED 160 0.0072
906 INJECTION SITE REACTION 493 0.0072
907 BLINDNESS 291 0.0071
908 SUICIDAL IDEATION 651 0.0071
909 HYPERKALAEMIA 248 0.0071
910 LUNG NEOPLASM MALIGNANT 290 0.0070
911 INJECTION SITE PRURITUS 468 0.0070
912 ABNORMAL BEHAVIOUR 275 0.0069
913 METABOLIC ACIDOSIS 219 0.0068
914 PRODUCT PRESCRIBING ISSUE 148 0.0068
915 VENTRICULAR TACHYCARDIA 112 0.0068
916 BLOOD GLUCOSE INCREASED 1272 0.0067
917 STEVENS-JOHNSON SYNDROME 150 0.0067
918 DEATH 5799 0.0067
919 CYTOKINE RELEASE SYNDROME 135 0.0067
920 DRUG EFFECT DECREASED 361 0.0067
921 INJECTION SITE MASS 247 0.0067
922 GLYCOSYLATED HAEMOGLOBIN INCREASED 167 0.0066
923 NEEDLE ISSUE 192 0.0066
924 MUCOSAL INFLAMMATION 172 0.0066
925 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 120 0.0065
926 SHOCK 150 0.0065
927 NERVOUS SYSTEM DISORDER 203 0.0065
928 HYPOGLYCAEMIA 315 0.0065
929 BLOOD GLUCOSE ABNORMAL 119 0.0064
930 INJECTION SITE URTICARIA 158 0.0064
931 INTENTIONAL OVERDOSE 412 0.0064
932 BLOOD GLUCOSE DECREASED 308 0.0064
933 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 455 0.0064
934 AGGRESSION 319 0.0064
935 INJECTION SITE ERYTHEMA 786 0.0063
936 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1271 0.0063
937 HEPATOTOXICITY 139 0.0062
938 INJECTION SITE SWELLING 477 0.0062
939 PRODUCT SUBSTITUTION ISSUE 357 0.0062
940 SKIN IRRITATION 281 0.0061
941 CARDIAC FAILURE 485 0.0060
942 PRODUCT QUALITY ISSUE 816 0.0060
943 MELAENA 132 0.0060
944 INJECTION SITE PAIN 1835 0.0060
945 INJECTION SITE WARMTH 122 0.0059
946 VISUAL ACUITY REDUCED 194 0.0058
947 HYPOCALCAEMIA 110 0.0058
948 WITHDRAWAL SYNDROME 244 0.0058
949 PSYCHOTIC DISORDER 171 0.0058
950 DRUG DOSE OMISSION 957 0.0058
951 NEOPLASM MALIGNANT 386 0.0058
952 DEVICE ISSUE 518 0.0058
953 INJECTION SITE HAEMORRHAGE 456 0.0057
954 CARDIAC ARREST 461 0.0056
955 DEPRESSED LEVEL OF CONSCIOUSNESS 219 0.0055
956 BLOOD CREATINE PHOSPHOKINASE INCREASED 156 0.0054
957 RASH MACULO-PAPULAR 117 0.0053
958 EPILEPSY 160 0.0052
959 INCORRECT DRUG ADMINISTRATION DURATION 144 0.0051
960 GAMMA-GLUTAMYLTRANSFERASE INCREASED 113 0.0051
961 SKIN BURNING SENSATION 362 0.0050
962 DERMATITIS ATOPIC 264 0.0050
963 CONVULSION 284 0.0050
964 ABORTION SPONTANEOUS 195 0.0049
965 DIABETIC KETOACIDOSIS 115 0.0048
966 DEVICE DISLOCATION 208 0.0048
967 ERECTILE DYSFUNCTION 119 0.0046
968 COMA 220 0.0046
969 DRUG INTERACTION 693 0.0044
970 DEVICE MALFUNCTION 294 0.0042
971 BREAST CANCER 388 0.0042
972 CARDIO-RESPIRATORY ARREST 174 0.0042
973 OSTEONECROSIS 135 0.0041
974 ANGIOEDEMA 179 0.0040
975 DRUG EXPOSURE DURING PREGNANCY 132 0.0039
976 ELECTROCARDIOGRAM QT PROLONGED 137 0.0038
977 HEPATIC FUNCTION ABNORMAL 138 0.0037
978 PRODUCT ADHESION ISSUE 132 0.0037
979 DEVICE LEAKAGE 160 0.0037
980 DRUG DEPENDENCE 593 0.0037
981 WRONG TECHNIQUE IN DRUG USAGE PROCESS 133 0.0037
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 152 0.0033
983 ACCIDENTAL EXPOSURE TO PRODUCT 334 0.0032
984 TOXICITY TO VARIOUS AGENTS 531 0.0031
985 DRUG WITHDRAWAL SYNDROME 272 0.0031
986 NO ADVERSE EVENT 529 0.0029
987 RHABDOMYOLYSIS 113 0.0027
988 DEVICE DIFFICULT TO USE 171 0.0026
989 PRODUCT STORAGE ERROR 221 0.0025
990 DRUG ABUSE 199 0.0024
991 PROSTATE CANCER 171 0.0021
992 COMPLETED SUICIDE 113 0.0014